CN1268027A - 草本提取物的化学和药理学标准化方法 - Google Patents

草本提取物的化学和药理学标准化方法 Download PDF

Info

Publication number
CN1268027A
CN1268027A CN98808588A CN98808588A CN1268027A CN 1268027 A CN1268027 A CN 1268027A CN 98808588 A CN98808588 A CN 98808588A CN 98808588 A CN98808588 A CN 98808588A CN 1268027 A CN1268027 A CN 1268027A
Authority
CN
China
Prior art keywords
extract
test
chemical
pharmacological activity
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98808588A
Other languages
English (en)
Chinese (zh)
Inventor
彼得·K·T·庞
杰奎琳·J·单
卡姆·W·丘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Afexa Life Sciences Inc
Original Assignee
CV Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Technologies Inc filed Critical CV Technologies Inc
Publication of CN1268027A publication Critical patent/CN1268027A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
CN98808588A 1997-08-28 1998-08-28 草本提取物的化学和药理学标准化方法 Pending CN1268027A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5609297P 1997-08-28 1997-08-28
US60/056,092 1997-08-28

Publications (1)

Publication Number Publication Date
CN1268027A true CN1268027A (zh) 2000-09-27

Family

ID=22002097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98808588A Pending CN1268027A (zh) 1997-08-28 1998-08-28 草本提取物的化学和药理学标准化方法

Country Status (8)

Country Link
US (1) US6156291A (enExample)
EP (1) EP1006802A4 (enExample)
JP (2) JP4520033B2 (enExample)
KR (1) KR20010023208A (enExample)
CN (1) CN1268027A (enExample)
AU (1) AU9029298A (enExample)
CA (1) CA2301860C (enExample)
WO (1) WO1999009837A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188724A (zh) * 2013-03-14 2015-12-23 张宗超 用于测定草药的活性成分及其产生的来源和催化途径的方法

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
DK1066042T3 (da) * 1998-03-26 2006-12-18 Phytopharm Plc Steroidale saponiner til behandling af Alzheimers sygdom
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
JP2001139483A (ja) * 1999-08-30 2001-05-22 Japan Science & Technology Corp 薬用人蔘からなる脳細胞または神経細胞保護剤
KR20020035855A (ko) 1999-08-30 2002-05-15 마쯔오 미쯔요시 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US6884627B2 (en) * 2002-04-05 2005-04-26 Advanced Gene Technology, Corp. Method for ascertaining the quality of herbs
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
WO2004040259A2 (en) * 2002-10-25 2004-05-13 Sloan-Kettering Institute For Cancer Research Screening, quantitation and identification of active ingredients in natural products
US7491753B2 (en) 2003-07-03 2009-02-17 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
KR20070057779A (ko) * 2004-07-16 2007-06-07 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 베타-아밀로이드 펩티드 생산을 저해함으로써알츠하이머병을 치료하는 화합물 및 이들의 제조
TWI285262B (en) * 2005-06-20 2007-08-11 Dev Center Biotechnology Characteristic mass spectrum fingerprinting setting method and rapid identification method of Chinese herb medicine and prescription
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
RU2444541C2 (ru) 2006-08-24 2012-03-10 Маллард Крик Полимерс, Инк. Катионный латекс в качестве носителя биоактивных ингредиентов и способы его получения и использования
KR101459805B1 (ko) * 2007-03-30 2014-11-07 9898 리미티드 천연 산물 개발을 위한 약제 플랫폼 기법
MY160074A (en) 2008-01-24 2017-02-15 Raptor Therapeutics Inc Protopanaxadiol-type ginsenoside compositions and uses thereof
JP5879037B2 (ja) 2008-02-29 2016-03-08 バレアント カナダ エルピー 人参抽出物による先天免疫応答および適応免疫応答の活性化
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
KR20110007473A (ko) * 2009-07-16 2011-01-24 씨제이제일제당 (주) 진세노사이드 강화 분획물을 포함하는 혈압 강하용 조성물
JP5563285B2 (ja) * 2009-12-14 2014-07-30 ライオン株式会社 飲食品、医薬品、又は医薬部外品、並びに、プロトパナキサトリオールの安定化方法、及びプロトパナキサジオールの安定化方法
US20110177179A1 (en) * 2010-01-18 2011-07-21 Sinoveda Canada, Inc. Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology
US20150044306A1 (en) 2013-08-12 2015-02-12 Melvin Mitchell Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals
US20160085941A1 (en) * 2015-03-13 2016-03-24 Jianyi Zhang Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis
WO2018222622A1 (en) 2017-05-27 2018-12-06 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
EP3638740B1 (en) 2017-06-16 2024-08-07 Poly Group LLC Polymeric antimicrobial surfactant
BE1027552B1 (fr) 2019-09-03 2021-03-30 Botalys Sa Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress
WO2021043389A1 (en) 2019-09-03 2021-03-11 Botalys Sa Ginseng composition and use thereof as a medicament for treatment or prevention of an impaired cognition
WO2021043927A1 (en) 2019-09-03 2021-03-11 Botalys Sa Ginseng composition and use thereof as a medicament
BE1027772B1 (fr) 2019-11-21 2021-06-21 Botalys Sa Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique
US10881983B2 (en) * 2019-09-18 2021-01-05 The Winning Combination Method for extraction of ethyl maltol from passion flower

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753397A (ja) * 1993-08-19 1995-02-28 Inahata Koryo Kk 変異原性抑制剤
JPH07126618A (ja) * 1993-11-04 1995-05-16 Jumoku Chushutsu Seibun Riyou Gijutsu Kenkyu Kumiai 抗酸化剤
EP0824355A4 (en) * 1995-04-14 1998-12-30 Univ Southern California Mistletoe extract and method
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US5547674A (en) * 1995-04-14 1996-08-20 University Of Southern California Pharmaceutical preparations derived from European mistletoe

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188724A (zh) * 2013-03-14 2015-12-23 张宗超 用于测定草药的活性成分及其产生的来源和催化途径的方法

Also Published As

Publication number Publication date
CA2301860C (en) 2009-05-26
US6156291A (en) 2000-12-05
EP1006802A4 (en) 2004-01-14
CA2301860A1 (en) 1999-03-04
JP2001513533A (ja) 2001-09-04
JP2009292844A (ja) 2009-12-17
KR20010023208A (ko) 2001-03-26
WO1999009837A1 (en) 1999-03-04
JP4520033B2 (ja) 2010-08-04
EP1006802A1 (en) 2000-06-14
AU9029298A (en) 1999-03-16
JP5491114B2 (ja) 2014-05-14

Similar Documents

Publication Publication Date Title
CN1268027A (zh) 草本提取物的化学和药理学标准化方法
Petkov et al. Effects of Standarized Ginseng extract on learning, memory and physical capabilites
EP2185167B1 (en) System and method for assessing traditional medicines
CN111693640A (zh) 一种保健食品中非法添加化合物的筛查方法
CN1357106A (zh) 药用植物制品的品质管制及标准化方法
CN113791152B (zh) 一种hplc法测定痫愈胶囊中多种有效成分含量的方法
CN104056281A (zh) 一种从中药或天然药物复杂体系中筛选活性成分的方法及其用途
CN112326849B (zh) 一种用于东革阿里的减肥降脂特性研究的生物样品分析方法
CN114755331A (zh) Uplc-q-tof法鉴别舒筋活血丸中6种组分的方法
CN1765374A (zh) 灵芝咀嚼片的制备方法及产品
CN101013111B (zh) 中药有效成分谱筛选方法
DE10393475T5 (de) Verfahren und Vorrichtung zur Identifizierung von Verbindungen in einer Probe
CN1244350C (zh) 一种具有健脾消积作用的中药组合物及其制备方法
CN1824238A (zh) 治疗抑郁症的药物制剂的质量控制方法
CN112924600A (zh) 一种治疗风湿痹阻所致关节肿痛制剂的指纹图谱建立方法
CN1911427A (zh) 一种治疗慢性泄泻的药物
CN1973855A (zh) 一种益母草注射剂
HK1027946A (en) Chemical and pharmacological standardization of herbal extracts
CN1824126A (zh) 滋阴补肾的口服制剂的质量控制方法
CN111474276B (zh) 一种健阳片制剂的质量控制方法
Muhtadi et al. The activity of isolate from ethyl acetate fraction of mahkota dewa (Phaleria macrocarpa (Scheff.) Boerl.) fruits on insulin sensitivity in hyperglycaemic mouse
CN1667411A (zh) 通用中草药、中成药、中药保健品色谱指纹图谱制定方法
CN110376311B (zh) 用于鉴别当归与混伪品东当归的方法
CN1830472A (zh) 中药材陈皮水提物的指纹图谱测定方法
CN114209718A (zh) 海马提取物的制备方法及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1027946

Country of ref document: HK